Evidence map›Paper›PMID 31666278›Full record

ArticleBMJ open2019

Pertussis over two decades: seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy.

Serena Marchi, Emanuele Montomoli, Edmond J Remarque, Geraldo Tadinho Monteverde Spencer, Angela Azzarello, Simonetta Viviani, Claudia Maria Trombetta

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06286007 (Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06286007 unknown statusnot on this mapstarted 2023, after this paper: background citation

Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control

Typeobservational_patient_registrySponsorHospital Clinico Universitario de SantiagoRan2023 to 2026Enrolled784ConditionsAsthma, Pertussis, RSV InfectionArmsPCR
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Serena MarchiDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.ORCID 0000-0002-6817-2461
Emanuele MontomoliDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.ORCID 0000-0001-7595-4974
Edmond J RemarqueDepartment of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Geraldo Tadinho Monteverde Spencer *Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Angela Azzarello *Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Simonetta VivianiDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Claudia Maria TrombettaDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy trombetta@unisi.it.ORCID 0000-0001-7229-9919
University of Siena · ITBiomedical Primate Research Centre · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate seroprevalence against

designSeroepidemiological study.

participants1812 serum samples collected in Tuscany from subjects older than 12 years from 1992 to 2005 and from 2013 to 2016. OUTCOME MEASURES: Specific antibody levels were determined by means of standard commercial ELISA using a dual cut-off of 50 and 125 IU/mL as markers of past and recent infection/vaccination, respectively.

resultsThe highest values of IgG titres were observed in 1992-1994 in all subjects (69.5 IU/mL), with prevalence values of subjects with IgG titres of >50 and >125 IU/mL of 68.3% and 23.8%, respectively. IgG titres decreased in the years thereafter (37.8 IU/mL in 2002-2005), together with prevalence values (41.7% and 8.1% in 2002-2005). In 2013-2016, both IgG titres and prevalence values showed a slight increase (50.6 IU/mL, 53.9% and 14.7%, respectively). IgG titres and prevalence followed the same age-related trend in all time periods considered, with the highest values in subjects aged 12-22 years. The lowest values were found in the age group of subjects aged 23-35 years (OR 0.54).

conclusionsSince 2002, approximately half of the population over 22 years of age have low IgG titres and are presumably susceptible to acquiring and transmitting pertussis infection. In addition, in 2013-2016, almost one-third of subjects aged 12-22 years, that is, the age group most likely to have been vaccinated against pertussis in infancy, had low antibody levels. Improving vaccination coverage and implementing careful surveillance are therefore recommended in order to prevent morbidity and mortality due to pertussis.

Indexed as

AdolescentAdultBordetella pertussisChildHumansImmunoglobulin GItalyPertussis VaccineSeroepidemiologic StudiesVaccination CoverageWhooping CoughYoung AdultImmunoglobulin GPertussis VaccineepidemiologyItalypertussisTuscany

Identifiers

PMID31666278
PMCPMC6830678
OpenAlexW2982493489

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.